GlaxoSmithKline (nyse: GSK - news - people ) is working on its own bird-flu vaccine.

FORBES: Can Vaccines Make Money?

GlaxoSmithKline is working on its own bird-flu vaccine.

FORBES: Magazine Article

China's science and health authorities plan to develop a vaccine for H7N9 bird flu within seven months, amid reports that the virus has been detected in ducks in Zhejiang province, the newspaper adds.

BBC: China media: Analysing North Korea